Holen Sie sich die Stockscreener-App
259.01
1.12%
-2.87
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LH?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Labcorp Holdings Inc Aktie (LH) Neueste Nachrichten
Labcorp Stock Climbs 25.6% This Year: What's Driving the Surge? - Nasdaq
Labcorp Launches Labcorp Whole Health Solutions to Support Holistic Care - marketscreener.com
Labcorp Revolutionizes Healthcare Testing with New 1000+ Biomarker Platform for Holistic Medicine - Stock Titan
Baird Adjusts Price Target on Labcorp Holdings to $290 From $268, Maintains Outperform Rating - MarketScreener
Morgan Stanley Hikes Labcorp (LH) Holdings Price Target to $283 Affirms ‘Overweight’ Rating - Yahoo Finance
FTRE INVESTOR DEADLINE: Robbins Geller Rudman & Dowd Announces that Fortrea Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve
Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTRE - FinancialContent
Kaplan Fox Reminds Fortrea Holdings Inc. (FTRE) Investors of a Securities Class Action Deadline on August 1, 2025 - FinancialContent
Class Standing Issues Still Murky After Justices Punt LabCorp - Law360
Labcorp (LH) Gains Exclusive 3D Liver Models from Predictive Onc - GuruFocus
Labcorp director Kerrii Anderson sells shares worth $130,000 By Investing.com - Investing.com Canada
Labcorp director Kerrii Anderson sells shares worth $130,000 - Investing.com Australia
Predictive Oncology Develops 3D Liver Toxicity Models for Labcorp - marketscreener.com
Predictive Oncology Inc. Develops Functional 3D Organoid Models Exclusively for Labcorp - MarketScreener
Kaplan Fox Encourages Investors of Fortrea Holdings Inc. (FTRE) to Contact the Firm Before Lead Plaintiff Deadline on August 1, 2025 - The Globe and Mail
Investing in Labcorp Holdings (NYSE:LH) five years ago would have delivered you a 85% gain - simplywall.st
Predictive Oncology Inc. Develops Exclusive 3D Organoid Models for Labcorp to Enhance Drug Discovery and Safety Evaluation - Nasdaq
Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp - Yahoo Finance
Labcorp Hldgs (LH) Price Target Raised by Morgan Stanley | LH St - GuruFocus
Kirby McInerney LLP Reminds Fortrea Holdings Inc. (FTRE) Investors of Class Action Filing and Encourages Investors to Contact the Firm - FinancialContent
Kaplan Fox Alerts Investors to a Securities Class Action Against Fortrea Holdings Inc. (FTRE)Deadline is August 1, 2025 - The Globe and Mail
Labcorp v. Davis Challenge Regarding Uninjured Class Members Dismissed as Improvidently Granted - Wilson Sonsini
What 8 Analyst Ratings Have To Say About Labcorp Hldgs - Benzinga
Just One Day Away – Register Now for HMG Strategy’s 9th Annual New York CISO & Technology Leadership Summit on June 12 - GlobeNewswire Inc.
Labcorp Hldgs (LH) Price Target Raised by Morgan Stanley | LH Stock News - GuruFocus
Analyst Boosts Price Target for Labcorp (LH) Amid Positive Growt - GuruFocus
Morgan Stanley Raises Price Target on Labcorp Holdings to $283 From $270 - marketscreener.com
LabCorp stock hits 52-week high at $258.7 amid robust growth By Investing.com - Investing.com South Africa
Justice Kavanaugh Signals One Conservative Vote in Labcorp Toward Imposing a Pre-Certification Standing Requirement Under FRCP 23 - The National Law Review
LabCorp stock hits 52-week high at $258.7 amid robust growth - Investing.com India
InStride Redefines Workforce Development Through Strategic Expansion - GlobeNewswire Inc.
FTRE INVESTOR ALERT: Fortrea Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve
SCOTUS Declines to Decide Fate of Classes with Uninjured Members: 8-1 Decision in LabCorp Leaves Unresolved Whether Rule 23 Allows Certification for a Class Containing Members Who Lack Standing - The National Law Review
SCOTUS DECLINES TO DECIDE FATE OF CLASSES WITH UNINJURED MEMBERS: 8-1 Decision In LabCorp Leaves Unresolved Whether Rule 23 Allows Certification For A Class Containing Members Who Lack Standing - TCPAWorld
Supreme Court backs off class-action case involving Labcorp, leaving legal questions unresolved - The Business Journals
Insider Sell: Brian Caveney Sells 2,000 Shares of Labcorp Holdin - GuruFocus
Should You Continue to Hold Labcorp Stock in Your Portfolio? - MSN
Labcorp EVP Brian Caveney sells $494,000 in common stock By Investing.com - Investing.com Canada
Labcorp EVP Brian Caveney sells $494,000 in common stock - Investing.com Australia
FTRE BREAKING NEWS: Fortrea Holdings Inc. Stock Plummets 25% Triggering Shareholder Class Action – Contact BFA Law if You Lost Money (NASDAQ:FTRE) - Business Wire
High Court Drops Class Cert. Clarification Bid - Law360
Labcorp Holdings Insider Sold Shares Worth $494,000, According to a Recent SEC Filing - marketscreener.com
Fortrea Faces Investor Suit Over Post-Labcorp Financial Woes - Law360
FTRE INVESTOR ALERT: Fortrea Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Fortrea Class Action Lawsuit - The Malaysian Reserve
FTRE Stockholder Alert: Robbins LLP Informs Investors of the Fortrea Holdings, Inc. Class Action Lawsuit - Morningstar
Labcorp Adds New Tests for Solid Tumors, Hematologic Malignancies - marketscreener.com
Labcorp Expands Oncology Portfolio to Improve Patient Care, Advance Cancer Research - marketscreener.com
Labcorp Expands Oncology Portfolio to Improve Patient Care and A - GuruFocus
Labcorp (LH) Expands Precision Oncology Portfolio with New Offerings | LH Stock News - GuruFocus
Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research - Financial Times
Labcorp Revolutionizes Cancer Care: New Test Portfolio Promises Faster Treatment Decisions - Stock Titan
Why Is Labcorp (LH) Up 2.5% Since Last Earnings Report? - Yahoo Finance
0.44%
1.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):